Cynata Therapeutics (ASX:CYP) Phase 3 knee osteoarthritis trial missed both endpoints, triggering a review of the entire Cymerus platform.
Healthcare Stocks
BCAL Diagnostics (ASX:BDX) unveiled BREASTEST Monitor, a blood test for breast cancer recurrence with 91% sensitivity in early validation data.
Intuitive Surgical (NDQ:ISRG) is one of the most important companies in modern medical technology. It pioneered robotic‑assisted surgery, built a global installed base that competitors have spent decades trying to replicate, and created one of the most durable recurring‑revenue machines in healthcare. But this does not mean it has been immune from challenges and has…
TALi Digital (ASX:TD1) has appointed Suubee founder George Rolleston as Audit Chair, signalling a likely shift in capital and M&A strategy.
Sigma Healthcare (ASX:SIG) has walked away from the Boots sale process, signalling capital discipline and shifting its UK growth onto the smaller Greenlight MoU.
KEY POINTS
Monash IVF (ASX: MVF) cut its FY26 profit forecast again, to between A$17 million and A$18 million, as fewer Australians start IVF.
The shares actually rose on the news (up 2.24% to A$0.68), a sign the bad news was already expected.
A A$0.90 takeover bid from the Soul Patts and…
OncoSil Medical (ASX:OSL) launched a new Investor Hub and flagged a catalyst-rich second half of 2026 spanning FDA, clinical and manufacturing milestones.
Microba Life Sciences (ASX:MAP) raises A$5m at a 20.6% discount with Sonic Healthcare backing the round, targeting CY2027 cashflow break-even.
Vitrafy Life Sciences (ASX:VFY) raises A$30m at a 31.6% discount to scale US operations ahead of the 2027 blood industry cryopreservation deadline.
Vitasora Health (ASX:VHL) closed a A$4 million placement at 2.7x its target, cornerstoned by a A$3 million cheque from Bob Peters.
